In the SafeBoosC-III trial, investigators are allowed to conduct secondary and ancillary studies. All such studies, must be approved by the steering committee. Secondary studies draw solely on data from the SafeBoosC-III OpenClinica database, i.e. data from the eCRF. Ancillary studies draw on data from the SafeBoosC-III database as well, but do also include data (additional variables or outcomes), that are not included in the SafeBoosC-III database, i.e. external data.
For the minutes, click here.
For an overview and status on ongoing as well as completed secondary and ancillary studies,
click here.
Secondary studies
Mechanical ventilation and late brain injury in the SafeBoosC-III trial
Ancillary studies
Research ethics boards decision on alternative consent methods in the SafeBoosC-III trial
Meta-analysis of “General Movement Assessments” conducted in neonates included in the SafeBoosC-III trial in different centres
Extremely preterm infant admissions within the SafeBoosC-III consortium during the COVID-19 lockdown
SafeBoosC-III MRI at term equivalent age
Quantification of flow-pressure cerebral autoregulation during transition in extremely preterm infants
Early cerebral desaturation events and intraventricular haemorrhage in extremely preterm infants